Switching between anti-CGRP monoclonal antibodies and gepants

Session 4: Current strategies and the future ahead

Taoufik Alsaadi

MD, Chairman, Neurology Department, Chief Medical Officer, American Center for Psychiatry & Neurology (ACPN), Abu Dhabi

Download presentation

Previous

The nurse, the backbone of medical care

Next

Can we modify the course of migraine?